Literature DB >> 25830522

Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation.

Wendy K Steagall1, Li Zhang, Xiong Cai, Gustavo Pacheco-Rodriguez, Joel Moss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25830522      PMCID： PMC4407489          DOI： 10.1164/rccm.201412-2170LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

1.  Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.

Authors:  Yoshihiko Ikeda; Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Souheil El-Chemaly; Bernadette R Gochuico; Rose M May; Olanda M Hathaway; Shaowei Li; Ji-an Wang; Thomas N Darling; Mario Stylianou; Joel Moss
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

2.  Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm.

Authors:  Francis X McCormack; William D Travis; Thomas V Colby; Elizabeth P Henske; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2012-12-15       Impact factor: 21.405

3.  Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis.

Authors:  Xiong Cai; Gustavo Pacheco-Rodriguez; Mary Haughey; Leigh Samsel; Suowen Xu; Hai-Ping Wu; J Philip McCoy; Mario Stylianou; Thomas N Darling; Joel Moss
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

Review 4.  Cancer dormancy: a model of early dissemination and late cancer recurrence.

Authors:  David Páez; Melissa J Labonte; Pierre Bohanes; Wu Zhang; Leonor Benhanim; Yan Ning; Takeru Wakatsuki; Fotios Loupakis; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2011-12-09       Impact factor: 12.531

5.  Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.

Authors:  Denise M Crooks; Gustavo Pacheco-Rodriguez; Rosamma M DeCastro; J Philip McCoy; Ji-an Wang; Fumiyuki Kumaki; Thomas Darling; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

6.  Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.

Authors:  T A Smolarek; L L Wessner; F X McCormack; J C Mylet; A G Menon; E P Henske
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

7.  Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.

Authors:  Xiong Cai; Gustavo Pacheco-Rodriguez; Qing-Yuan Fan; Mary Haughey; Leigh Samsel; Souheil El-Chemaly; Hai-Ping Wu; J Philip McCoy; Wendy K Steagall; Jing-Ping Lin; Thomas N Darling; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2010-07-16       Impact factor: 21.405

Review 8.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

9.  Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Connie G Glasgow; Yoshihiko Ikeda; Jing-Ping Lin; Gang Zheng; Joel Moss
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

Review 10.  Lymphangioleiomyomatosis - a wolf in sheep's clothing.

Authors:  Elizabeth P Henske; Francis X McCormack
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808
View more
  5 in total

Review 1.  The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Thomas N Darling; Olga Torre; Sergio Harari; Joel Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 6.914

Review 2.  Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Authors:  Hen Prizant; Stephen R Hammes
Journal:  Endocrinology       Date:  2016-07-13       Impact factor: 4.736

3.  Circulating Lymphangioleiomyomatosis Tumor Cells With Loss of Heterozygosity in the TSC2 Gene Show Increased Aldehyde Dehydrogenase Activity.

Authors:  Gustavo Pacheco-Rodríguez; Wendy K Steagall; Leigh Samsel; Pradeep K Dagur; J Philip McCoy; Ilker Tunc; Mehdi Pirooznia; Ji-An Wang; Thomas N Darling; Joel Moss
Journal:  Chest       Date:  2019-04-26       Impact factor: 9.410

4.  Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene.

Authors:  Davide Elia; Olga Torre; Chiara Vasco; Jens Geginat; Sergio Abrignani; Elisabetta Bulgheroni; Elena Carelli; Roberto Cassandro; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Joel Moss; Sergio Harari
Journal:  Chest       Date:  2022-02-26       Impact factor: 10.262

5.  Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Authors:  Gorka Ruiz de Garibay; Carmen Herranz; Alicia Llorente; Jacopo Boni; Jordi Serra-Musach; Francesca Mateo; Helena Aguilar; Laia Gómez-Baldó; Anna Petit; August Vidal; Fina Climent; Javier Hernández-Losa; Álex Cordero; Eva González-Suárez; José Vicente Sánchez-Mut; Manel Esteller; Roger Llatjós; Mar Varela; José Ignacio López; Nadia García; Ana I Extremera; Anna Gumà; Raúl Ortega; María Jesús Plà; Adela Fernández; Sònia Pernas; Catalina Falo; Idoia Morilla; Miriam Campos; Miguel Gil; Antonio Román; María Molina-Molina; Piedad Ussetti; Rosalía Laporta; Claudia Valenzuela; Julio Ancochea; Antoni Xaubet; Álvaro Casanova; Miguel Angel Pujana
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.